{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-217504","form_type":"8-K","ticker":"ZBH","cik":"0001136869","company_name":"ZIMMER BIOMET HOLDINGS, INC.","filed_at":"2023-08-22T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.220653+00:00","generated_at":"2026-06-11T05:20:19.776618+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Zimmer Biomet appoints Ivan Tornos as CEO, Christopher Begley as Chairman; Suketu Upadhyay expands role","bullets":["Bryan Hanson steps down as Chairman, President & CEO effective Aug 22, 2023; remains advisory through Aug 31.","Ivan Tornos, former COO, appointed President & CEO; elected to Board.","Christopher Begley appointed Chairman of the Board (from Lead Independent Director).","Suketu Upadhyay expands role to CFO & EVP, Finance, Operations & Supply Chain.","Company reaffirms full-year 2023 financial guidance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-217504","json":"https://secwatch.observer/filing/0001193125-23-217504.json","markdown":"https://secwatch.observer/filing/0001193125-23-217504.md","text":"https://secwatch.observer/filing/0001193125-23-217504.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1136869/000119312523217504/0001193125-23-217504-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1136869/000119312523217504/d535846d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T05:20:19.776618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b16204d3d","claim":"Bryan C. Hanson departed as Chairman of the Board, President and Chief Executive Officer at ZIMMER BIOMET HOLDINGS, INC..","evidence_excerpt":"On August 17, 2023, Bryan C. Hanson notified the Company that he planned to step down as Chairman of the Board, President and Chief Executive Officer of the Company and as a member of the Company’s Board, all effective as of August 22, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312523217504/0001193125-23-217504-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down"},{"label":"Role","value":"Chairman of the Board, President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"a62d55b3a6","claim":"Christopher B. Begley was appointed as Chairman of the Board at ZIMMER BIOMET HOLDINGS, INC..","evidence_excerpt":"Effective August 22, 2023, the Board appointed Christopher B. Begley, who has been a director of the Company since 2012 and the Lead Independent Director since May 2021, to be the Chairman of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312523217504/0001193125-23-217504-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"},{"claim_id":"bbb98727a8","claim":"Ivan Tornos was appointed as President and Chief Executive Officer at ZIMMER BIOMET HOLDINGS, INC..","evidence_excerpt":"Effective August 22, 2023, the Board appointed Ivan Tornos the Company’s President and Chief Executive Officer, and elected Mr. Tornos a member of the Board of Directors to fill the vacancy resulting from Mr. Hanson’s departure from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312523217504/0001193125-23-217504-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"President and Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"c13a9738f1","claim":"Ivan Tornos was elected as Member of the Board of Directors at ZIMMER BIOMET HOLDINGS, INC..","evidence_excerpt":"Effective August 22, 2023, the Board appointed Ivan Tornos the Company’s President and Chief Executive Officer, and elected Mr. Tornos a member of the Board of Directors to fill the vacancy resulting from Mr. Hanson’s departure from the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312523217504/0001193125-23-217504-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"elected"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"},{"claim_id":"c7a8d4ee23","claim":"Suketu Upadhyay was appointed as Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain at ZIMMER BIOMET HOLDINGS, INC..","evidence_excerpt":"Additionally, effective August 22, 2023, Suketu Upadhyay has been appointed to the newly-created position of Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1136869/000119312523217504/0001193125-23-217504-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer and Executive Vice President – Finance, Operations and Supply Chain"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}